Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 477-690-9 | CAS number: 874819-71-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2004-08-24 - 2004-10-27
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The GLP study was conducted according to an internationally accepted guideline. All study parameters are based on the specific guideline.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 004
- Report date:
- 2004
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
- Limit test:
- yes
Test material
- Reference substance name:
- -
- EC Number:
- 477-690-9
- EC Name:
- -
- Cas Number:
- 874819-71-3
- Molecular formula:
- Hill formula: C6H9N4O3P CAS formula: C6H9N4O3P
- IUPAC Name:
- N-(diaminophosphoryl)-2-nitroaniline
- Test material form:
- solid: crystalline
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- water
- Details on dermal exposure:
- Approximately 24 hours before administration the fur was removed by shaving from the dorsal area (6x6 cm) of the trunk. Only animals with healthy intact skin were used. 0.2 g / 100 g body weight
Individual doses were adjusted according to the recorded body weight.
The test item was moistened with deionised water, applied to the shaved skin area and covered with a layer of a gaze patch and then with aluminium foil (6.5 x 6.5 cm). This patch was held in contact with the skin by occlusive dressing (Elastoplast, Beiersdorf AG), single administration on September 07, 2004, 9.25 - 9.59 a.m. After 24 hours the patch was removed and the application area was cleaned with water without altering the integrity of the epidermis. - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 5 male and 5 female animals
- Control animals:
- not required
- Details on study design:
- Observations
The animals were observed over a period of 14 days after administration of the test item.
Mortality
Animals were observed for mortality and morbidity continuously on the day of administration and once daily thereafter (in the morning).
Clinical Observations
The animals were monitored for general clinical condition continuously on the day of administration and once daily thereafter (in the morning).
The following signs were given predominant consideration: changes in skin, fur, eyes and mucous membranes; gait and posture; respiratory, circulatory, autonomic and central nervous system; occurrence of secretions and excretions; presence of clonic or tonic movements and stereotypies or bizarre behaviour.
Skin of the Administration Area
Animals were observed for erythema and/or oedema at the skin of the administration area one hour after patch removal and once daily thereafter (in the morning).
Body Weight Gain
Body weights were recorded on the day of administration and on days 7 and 14 thereafter.
Pathology
At the end of the observation period all animals were killed by CO2 inhalation.
All animals were examined externally. The cranial, thoracic and abdominal cavities were then opened and examined macroscopically. - Statistics:
- Body weights and body weight gain:
Calculation of group mean values and standard deviations.
Comparison with historical control data.
Results and discussion
- Preliminary study:
- None of the animals died after a single dermal administration of 2000 mg/kg b.w. AL(2-NitrophenyI)phosphoric triamide.
Clinical signs were not observed during the observation period.
Except for a slightly yellowish discolouring not any alteration of the skin at the administration area was observed.
The body weight gain of the animals was not affected by the test item. No pathological findings were observed at necropsy.
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- none
- Clinical signs:
- other: None of the animals showed alterations of the general state of well-being during the course of investigation.
- Gross pathology:
- There were no macroscopic pathological findings in the animals.
Applicant's summary and conclusion
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The dermal LD50 of N-(2-Nitrophenyl)phosphoric triamide in the rat is > 2000 mg/kg b.w.
- Executive summary:
Acute dermal toxicity of N-(2 -Nitrophenylphosphoric triamide was tested in 5 male and 5 female Charles River Wistar rats according to OECD guideline 402. The test item was applied at a single dose of 2000 mg/kg body weight to a shaved dorsal area of the trunk of the animals and was then covered with a gauze patch which was held in contact with the skin with an occlusive dressing. Exposure was for 24 hours. Animals were examined for mortality, clinical signs, alterations of the administration area, body weight gain and pathological alterations of organs at the end of a 14-day observation period, None of the animals died during the course of the investigation. The LD50 dermal rat is > 2000 mg/kg b.w. Clinical signs were not observed during the observation period. Except for a slightly yellowish discolouring not any alteration of the skin at the administration area was observed. The body weight gain of the animals was not affected by the test item. No pathological findings were observed at necropsy.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
